EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2025 (TTM): C$0.17

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is C$0.18. In 2024 the company made an earnings per share (EPS) of C$0.19 an increase over its 2023 EPS that were of C$0.13.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2025

Annual EPS

Year	EPS	Change
2025 (TTM)	C$0.17	-7.94%
2024	C$0.19	42.43%
2023	C$0.13	8.77%
2022	C$0.12	-20.62%
2021	C$0.15	-26.59%
2020	C$0.21	27.24%
2019	C$0.16	28.41%
2018	C$0.13	20.04%
2017	C$0.11	31.21%
2016	C$0.08122	11.46%
2015	C$0.07287	36.27%
2014	C$0.05347	19.77%
2013	C$0.04464	18.05%
2012	C$0.03782	23.9%
2011	C$0.03052	26.9%
2010	C$0.02405	12.37%
2009	C$0.02141	56.6%
2008	C$0.01367	9.18%
2007	C$0.01252	114.48%
2006	C$0.005838	64.83%
2005	C$0.003542	35.55%
2004	C$0.002613	29.73%
2003	C$0.002014	19.86%
2002	C$0.001680	-2.71%
2001	C$0.001727	1.02%
2000	C$0.001710

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions